Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will report third quarter 2025 financial results after the close of trading on Monday, November 3, 2025. Management will host a conference call at 5:00 p.m. Eastern Time to discuss results and recent business developments.

A live webcast will be available on the company’s Investor Relations page and registrants who intend to ask questions must register to receive dial‑in details and a unique access code. The company recommends registering at least 10 minutes before the call. A replay will be posted on the Investor Relations site about two hours after the call and will be archived for two weeks.

News Market Reaction – INSP

-0.27%

1 alert

-0.27% News Effect

On the day this news was published, INSP declined 0.27%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2025 after the close of trading on Monday, November 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q3 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (INSP) report Q3 2025 results?

Inspire will release Q3 2025 results after market close on Monday, November 3, 2025.

What time is the INSP Q3 2025 earnings call and how can I join?

The call begins at 5:00 p.m. ET; join via the live webcast on the company's Investor Relations page or register to receive dial‑in details.

How do I register to ask a question on the INSP Q3 2025 call?

Use the company’s registration link for the Q3 2025 earnings call; after registering you will receive an email with dial‑in details and a unique access code.

When will the Q3 2025 earnings replay for INSP be available?

A replay will be posted about two hours after the live call and will remain archived on the Investor Relations site for two weeks.

Where can investors find the INSP Q3 2025 webcast link?

The webcast link will be available on Inspire’s Investor Relations webpage and through the company’s published Q3 2025 earnings call link.

Any registration tips for the INSP November 3, 2025 earnings call?

Register early and no later than 10 minutes before the call to ensure you receive the access code and connect on time.